Autolus Therapeutics Plc (AUTL)
1.63
+0.04
(+2.52%)
USD |
NASDAQ |
Dec 12, 11:12
Autolus Therapeutics Research and Development Expense (Quarterly): 27.72M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Adaptimmune Therapeutics Plc | 25.95M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 2.928M |
| Mereo BioPharma Group Plc | 4.244M |
| Bicycle Therapeutics Plc | 65.65M |